food drug administration sacrificing american life continuing approve new high strength opioid painkiller manipulating process favor big pharma according chair agency opioid advisory committee dr raeford brown told guardian war within fda official charge opioid policy failed learn lesson epidemic killed hundred thousand people past 20 year continues claim 150 life day brown accused agency putting interest narcotic manufacturer ahead public health recently approving terrible drug dsuvia process alleged manipulated stop considering new opioid evaluation said brown every day every week every month fda right thing people drop dead street what direct impact mortality rate opioids country brown anesthesiologist chair fda committee specialist advising agency whether approve new opioid painkiller said longer confidence repeated assurance fda leadership taking epidemic seriously prepared put public health commercial interest drug maker region drug company marketed hit hardest opioids crisis read think fda learned nothing the modus operandi agency talk good game nothing happens working directly agency last five year sit listen meeting think clock ticking many people dying every moment anything said lack insight continues exhibited agency many way willful blindness border criminal brown comment echo criticism senator condemned fda say complicity epidemic approving powerful painkiller drove crisis failing use power protect public death toll escalated four senator wrote head fda dr scott gottlieb late last year urging allow dsuvia powerful opioid pill market detriment public health dsuvia branded narcotic sufentanil pill potent version fentanyl made californian pharmaceutical company acelrx the signatory included senator joe manchin west virginia whose state highest rate opioid overdose death country puzzling unacceptable course event unfortunately reminiscent previous fda process practice contributed opioid epidemic letter said fda credibility badly damaged opioid crisis amid accusation time behaved le regulator overseeing pharmaceutical industry business partner drug manufacturer the agency helped unleash epidemic two decade ago approved sale high strength narcotic pill oxycontin safer effective painkiller say manufacturer purdue pharma without requiring clinical trial since fda approved opioids wide prescribing even evidence mounted drug addictive open abuse often effective long term use fda also embarrassed revelation official responsible opioid approval taking part pay play scheme manufacturer paid attend meeting draw criterion approving prescription narcotic donald trump opioid commission identified failure fda federal institution properly regulate opioids manufacturer important factor epidemic trump appointed gottlieb new fda chief admitted agency get ahead crisis promised dramatic action he said favoured examining whether opioid worked whether needed whether risk feeding epidemic outweighed benefit patient commitment called question slow pace introducing new practice regulation approval dsuvia potent pill developed defense department advisory committee rejected drug 2017 safety concern the senator said deeply troubled dsuvia resubmitted consideration following year fda excluded member agency drug safety committee hearing the senator also said concerned decision made brown strong critic dsuvia absent professional conference san francisco question mind right purpose said fda lack transparency they use advisory committee cover fda required follow decision advisory committee wary going decision since 2012 agency created political storm overruling decision reject zohydro opioid 10 time powerful regular painkiller doctor specialist committee questioned safety drug need given epidemic the senior fda official hearing dr bob rappaport head agency opioid approval division angered member telling level playing field business widely interpreted putting right pharmaceutical company make money ahead public health brown described breakdown confidence trust advisory committee fda official responsible opioid approval he characterized touch consequence epidemic locked view promoted drugmakers become hooked blame addiction pill prescribing practice brown blamed problem part cozy cozy relationship pharmaceutical industry various part fda since change fda funding 1990s agency division responsible opioid approval relies drug industry 75 budget the agency denies money buy influence fda declined respond brown specific criticism gottlieb previously defended dsuvia saying required use circumstance drug administered battlefield the fda chief promised tight restriction distribution stop drug appearing illicit market he insisted fda learned much harmful impact prescription opioids brown remains skeptical nothing fundamentally done effect change regulation opioids if fda continues encourage pharmaceutical industry turn opioid opioid opioid regulation opioids better 1995 cleaning long time said brown chris mcgreal author american overdose opioid tragedy three act